https://www.fiercebiotech.com/biotech/sotio-stops-il-15-trials-cytokine-falls-short-solid-tumors-dealing-another-blow-once-hot
Sotio scrapped ongoing studies of its IL-15 superagonist after seeing insufficient efficacy in the clinic.
sotiostopsiltrialscytokine